Shereen Ezzat

Active 1991–2025

116
Papers
18,269
Citations
78
h-index
113
i10-index

Citations

Citations per year for Shereen Ezzat1991: 1 citations1992: 6 citations1993: 7 citations1994: 6 citations1995: 13 citations1996: 11 citations1997: 36 citations1998: 54 citations1999: 51 citations2000: 87 citations2001: 88 citations2002: 137 citations2003: 128 citations2004: 118 citations2005: 143 citations2006: 172 citations2007: 130 citations2008: 167 citations2009: 156 citations2010: 116 citations2011: 146 citations2012: 131 citations2013: 91 citations2014: 102 citations2015: 136 citations2016: 69 citations2017: 80 citations2018: 86 citations2019: 319 citations2020: 343 citations2021: 345 citations2022: 250 citations2023: 181 citations2024: 366 citations2025: 155 citations2026: 5 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,357 citing papers, 25.2% of this breakdownItaly: 472 citing papers, 8.8% of this breakdownUnited Kingdom: 348 citing papers, 6.5% of this breakdownChina: 333 citing papers, 6.2% of this breakdownCanada: 304 citing papers, 5.7% of this breakdownFrance: 251 citing papers, 4.7% of this breakdownGermany: 239 citing papers, 4.4% of this breakdownJapan: 165 citing papers, 3.1% of this breakdownNetherlands: 159 citing papers, 3% of this breakdownSpain: 151 citing papers, 2.8% of this breakdownAustralia: 137 citing papers, 2.5% of this breakdownSwitzerland: 104 citing papers, 1.9% of this breakdown
0%25.2%Other 25.2%

Fields

  • Medicine77.9%
  • Biochemistry, Genetics and Molecular Biology17.8%
  • Immunology and Microbiology1.2%
  • Neuroscience0.8%
  • Computer Science0.4%
  • Health Professions0.4%
  • Other1.5%

Topics

  • Pituitary Gland Disorders and Treatments10.4%
  • Thyroid Cancer Diagnosis and Treatment8.3%
  • Growth Hormone and Insulin-like Growth Factors5.5%
  • Neuroendocrine Tumor Research Advances5.3%
  • Adrenal and Paraganglionic Tumors3.9%
  • Thyroid Disorders and Treatments2.8%
  • Other63.8%

Coauthors

All papers

Open in search
  1. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms

    Authors: , , , , , , , , , , - Endocrine Pathology 2022 cited by 957

  2. The prevalence of pituitary adenomas

    Authors: , , , , , , - Cancer 2004 cited by 1,350

  3. A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jakob Regberg, Robert E. Roses, Anil K. Rustgi, Antonia R. Sepulveda, Stefano Serra, Chanjuan Shi, Xiaopu Yuan, Massimo Barberis, Roberto Bergamaschi, Arul M. Chinnaiyan, Tony Detre, Shereen Ezzat, Andrea Frilling, Merten Hommann, Dirk Jaeger, Michelle K. Kim, Beatrice S Knudsen, Andrew L. Kung, Emer Leahy, David C. Metz, Jeffrey W. Milsom, Young Shin Park, Diane Reidy‐Lagunes, Stuart L. Schreiber, Kay Washington, Bertram Wiedenmann, Irvin M. Modlin, Andrea Califano - Nature Genetics 2018 cited by 226

  4. From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , _ _ - Endocrine Related Cancer 2017 cited by 352

  5. Long-Term Late Toxicity, Quality of Life, and Emotional Distress in Patients With Nasopharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy

    Authors: , , , , , , , , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2018 cited by 183

  6. A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial

    Authors: , , , , , , , , , , , , , - British Journal of Cancer 2019 cited by 122

  7. Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Modern Pathology 2021 cited by 84

  8. A Quantitative Analysis Examining Patients' Choice of Active Surveillance or Surgery for Managing Low-Risk Papillary Thyroid Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vinita Bindlish, Maky Hafidh, Jose Prudencio, Vinod Bharadwaj, Manish D. Shah, Ilana Halperin, Danny Enepekides, Kevin Higgins, Karim Nazarali, Lorne Segall, Karen Devon, Michael Chang, Eric Arruda, Artur Gevorgyan, Vinay T. Fernandes, Philip Solomon, Jennifer Anderson, Andres Gantous, Denny Lin, Laura Whiteacre, Sumeet Anand, Mark Korman, Michael Odell, Marshall Hay - Thyroid 2022 cited by 44

  9. Pathogenetic mechanisms in thyroid follicular-cell neoplasia

    Authors: , , - Nature reviews. Cancer 2006 cited by 894

  10. The Pathogenesis of Pituitary Tumors

    Authors: , - Annual Review of Pathology Mechanisms of Disease 2009 cited by 258

  11. The Clinicopathological Spectrum of Parathyroid Carcinoma

    Authors: , , , , , , - Frontiers in Endocrinology 2019 cited by 48

  12. A Prospective Mixed-Methods Study of Decision-Making on Surgery or Active Surveillance for Low-Risk Papillary Thyroid Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Thyroid 2020 cited by 67

  13. An Institutional Experience of Tumor Progression to Pituitary Carcinoma in a 15-Year Cohort of 1055 Consecutive Pituitary Neuroendocrine Tumors

    Authors: , , , - Endocrine Pathology 2019 cited by 66

  14. A Systematic Review and Meta-Analysis of the Diagnostic Performance of BRAF V600E Immunohistochemistry in Thyroid Histopathology

    Authors: , , , , , , , , - Endocrine Pathology 2019 cited by 43

  15. Second Primary Malignancy Risk After Radioactive Iodine Treatment for Thyroid Cancer: A Systematic Review and Meta-analysis

    Authors: , , , , , , , , - Thyroid 2009 cited by 349

  16. Insulin and related factors in premenopausal breast cancer risk

    Authors: , , , , , - Breast Cancer Research and Treatment 1998 cited by 311

  17. The Implication of Somatotroph Adenoma Phenotype to Somatostatin Analog Responsiveness in Acromegaly

    Authors: , , , , - The Journal of Clinical Endocrinology & Metabolism 2005 cited by 190

  18. A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors

    Authors: , , , , , , , , , , , - Clinical Endocrinology 2008 cited by 178

  19. Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas

    Authors: , , , , , , , - Modern Pathology 2016 cited by 150

  20. Diagnosis and Pathologic Characteristics of Medullary Thyroid Carcinoma—Review of Current Guidelines

    Authors: , , , , - Current Oncology 2019 cited by 132

  21. Cancer-Related Worry in Canadian Thyroid Cancer Survivors

    Authors: , , , , , - The Journal of Clinical Endocrinology & Metabolism 2014 cited by 82

  22. The Clinicopathological Spectrum of Acromegaly

    Authors: , , , , - Journal of Clinical Medicine 2019 cited by 72

  23. Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ariel Barkan, John Barton, Julian Barwell, P. C. Bates, Carmen Bernal-González, Michael Besser, John S. Bevan, Alex Bickerton, Joanne Blair, Marek Bolanowski, Pierre Bouloux, Lisa Bradley, Karin Bradley, Caroline Brain, Antonia Brooke, Roger Brown, Michael Buchfelder, Christine Burren, Mehtap Çakır, Natalie Canham, Joël Capraro, Paul Carroll, Philippa Carter, David Carty, Dominic Cavlan, Harvinder Chahal, Tim Cheetham, F. Chentli, Catherine S. Choong, Mirjam Christ‐Crain, Teng‐Teng Chung, Peter Clayton, Richard N. Clayton, Mark L. Cohen, Hamish Courtney, David J. Cove, Elizabeth Crowne, Daniel J. Cuthbertson, Jacob Dal, Nadezhda Dalantaeva, Svetozar Damjanović, Christina Daousi, Ken Darzy, Mehul Dattani, Michaela Davies, Justin Davies, J.R. Davis, Margaret de Castro, Laura De Marinis, Cheri Deal, Judit Dénes, Paul Dimitri, Neil Dorward, Graham Dow, William Drake, Maralyn Druce, Juliana Drummond, Pinaki Dutta, Larisa Dzeranova, Britt Edén Engström, Rosalind A. Eeles, Maria Elfving, Kate Ellis, Marianne S. Elston, Louise Emmerson, Shereen Ezzat, Naomi Fersht, Simona Fica, Stefan Fischli, Maria Fleseriu and 183 more - The Journal of Clinical Endocrinology & Metabolism 2020 cited by 70

  24. An Update on Pituitary Neuroendocrine Tumors Leading to Acromegaly and Gigantism

    Authors: , - Journal of Clinical Medicine 2021 cited by 35